Tel Aviv, Israel

Sharon Furman-Assaf

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Allon Therapeutics, Inc., Tel Aviv University. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sharon Furman-Assaf. Retrieved from https://idiyas.com/inventor/sharon-furman-assaf

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Sharon Furman-Assaf

Introduction

Sharon Furman-Assaf is a notable inventor based in Tel Aviv, Israel. She has made significant contributions to the field of neuroprotection through her innovative research and development of peptide mimetics. Her work focuses on addressing critical issues related to neuronal dysfunction and neurodegenerative disorders.

Latest Patents

Sharon holds a patent for "Neuroprotection using NAP-like and SAL-like peptide mimetics." This invention relates to the use of NAP-like and SAL-like peptide mimetics, polypeptides, or small molecules derived from them. The patent addresses their application in treating neuronal dysfunction, neurodegenerative disorders, cognitive deficits, neuropsychiatric disorders, and autoimmune diseases. She has 1 patent to her name.

Career Highlights

Throughout her career, Sharon has worked with prominent organizations, including Allon Therapeutics, Inc. and Tel Aviv University. Her experience in these institutions has allowed her to advance her research and contribute to the scientific community significantly.

Collaborations

Sharon has collaborated with talented individuals such as Maya Maor and Alistair Stewart. These partnerships have enriched her work and fostered innovation in her field.

Conclusion

Sharon Furman-Assaf's contributions to neuroprotection and her innovative approach to peptide mimetics highlight her importance as an inventor. Her work continues to pave the way for advancements in treating neurodegenerative disorders and related conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…